ÂÜÀòÂÒÂ×

Pierre Le Sourd has been the Chair of Specia Laboratories, of the group Juveinal, then Bristol-Myers Squibb France and the group UPSA.

He has also served as a Chair for Leem (Les Entreprises du Médicament) and as a Vice-Chair for the French Federation of Health industries (Fédération Française des Industries de Santé, FEFIS).

He is currently Chief Financial Officer at XERYS, Director of ABCD Innovation, and Treasurer of the Automobile Club Médical in France.

He contributes to Alzprotect with his excellent knowledge of pharmaceutical markets, with both a medical and an industrial approach.